Guylène Page

8.9k total citations
75 papers, 2.4k citations indexed

About

Guylène Page is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Guylène Page has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 27 papers in Cellular and Molecular Neuroscience and 26 papers in Physiology. Recurrent topics in Guylène Page's work include Alzheimer's disease research and treatments (23 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers) and Neuroscience and Neuropharmacology Research (19 papers). Guylène Page is often cited by papers focused on Alzheimer's disease research and treatments (23 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers) and Neuroscience and Neuropharmacology Research (19 papers). Guylène Page collaborates with scholars based in France, Belgium and Egypt. Guylène Page's co-authors include Bernard Fauconneau, Agnès Rioux Bilan, Marc Paccalin, Jacques Hugon, Stéphanie Pain, Laurence Barrier, Claire Lafay‐Chebassier, Faraj Terro, Sabrina Ingrand and Thierry Janet and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Guylène Page

75 papers receiving 2.4k citations

Peers

Countries citing papers authored by Guylène Page

Since Specialization

Citations

This map shows the geographic impact of Guylène Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guylène Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guylène Page more than expected).

Fields of papers citing papers by Guylène Page

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guylène Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guylène Page. The network helps show where Guylène Page may publish in the future.

Co-authorship network of co-authors of Guylène Page

This figure shows the co-authorship network connecting the top 25 collaborators of Guylène Page. A scholar is included among the top collaborators of Guylène Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guylène Page. Guylène Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationships between Gut Microbiota and Autism Spectrum Disorders: Development and Treatment 2024 ·Clinical Psychopharmacology and Neuroscience ·(unknown), Guylène Page, Vincent Thoreau, (unknown)	4
2	Physiologically-based pharmacokinetic models to predict drug exposure during pregnancy 2023 ·Annales Pharmaceutiques Françaises ·(unknown), Guylène Page, Vincent Thoreau	2
3	Allelic Variants on SLC6A3 Neurotransmitter Gene and Their Relationship with Personality Traits Scales in Egyptian Athletes 2023 ·(unknown), (unknown), Guylène Page, Véronique Ladevèze	1
4	Blue marine therapy: Sea as a trove of natural anticancer drugs 2023 ·Annales Pharmaceutiques Françaises ·(unknown), Guylène Page, Vincent Thoreau	2
5	Natural stilbenes effects in animal models of Alzheimer’s disease 2019 ·Neural Regeneration Research ·Agnès Rioux Bilan, (unknown), Guylène Page, Bernard Fauconneau	49
6	Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer’s patients in a human blood brain barrier model 2018 ·PLoS ONE ·(unknown), Guylène Page, Marc Paccalin, (unknown), Thierry Janet	10
7	Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice 2018 ·Journal of Neuroinflammation ·(unknown), Thierry Janet, (unknown), Bernard Fauconneau, (unknown), Guylène Page	22
8	Relevance of electroencephalogram assessment in amyloid and tau pathology in rat 2018 ·Behavioural Brain Research ·(unknown), Guylène Page, Thierry Janet, Ronald L. Klein, (unknown), (unknown), Serge Richard, Pascal Champéroux, Bernard Fauconneau	7
9	Neuroprotective effect of the alpha 7 nicotinic receptor agonist PHA 543613 in an in vivo excitotoxic adult rat model 2017 ·Neuroscience ·(unknown), (unknown), Guylène Page, (unknown), Patrick Emond, Nuno F. Rodrigues, Frédéric Dollé, (unknown), Frédéric Buron, Sylvain Routier, Sylvie Chalon, Daniel Antier	28
10	Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice 2014 ·Journal of Neuroinflammation ·Arnaud François, Agnès Rioux Bilan, Nathalie Quellard, Béatrice Fernandez, Thierry Janet, (unknown), Marc Paccalin, Faraj Terro, Guylène Page	75
11	Tyk2/STAT3 Signaling Mediates β-Amyloid-Induced Neuronal Cell Death: Implications in Alzheimer's Disease 2010 ·Journal of Neuroscience ·Jun Wan, Amy K.Y. Fu, Fanny C.F. Ip, Ho‐Keung Ng, Jacques Hugon, Guylène Page, Jerry H. Wang, Kwok‐On Lai, Zhenguo Wu, Nancy Y. Ip	112
12	EphrinA5 protein distribution in the developing mouse brain 2010 ·BMC Neuroscience ·(unknown), (unknown), Thierry Janet, Guylène Page, Mohamed Jaber, Afsaneh Gaillard, Laetitia Prestoz	17
13	Evidence of molecular links between PKR and mTOR signalling pathways in Aβ neurotoxicity: Role of p53, Redd1 and TSC2 2009 ·Neurobiology of Disease ·(unknown), Julien Couturier, Raymond Pontcharraud, Roger Gil, Bernard Fauconneau, Marc Paccalin, Guylène Page	28
14	Gender-dependent accumulation of ceramides in the cerebral cortex of the APPSL/PS1Ki mouse model of Alzheimer’s disease 2008 ·Neurobiology of Aging ·Laurence Barrier, Sabrina Ingrand, Bernard Fauconneau, Guylène Page	31
15	Neuroprotective effects of pituitary adenylate cyclase–activating polypeptide (PACAP) in MPP⁺‐induced alteration of translational control in Neuro‐2a neuroblastoma cells 2007 ·Journal of Neuroscience Research ·Julie Deguil, (unknown), Guylène Page, Bernard Fauconneau, Jean‐Luc Houéto, Michel Philippe, Müller Jm, Stéphanie Pain	35
16	Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells 2002 ·Neurochemistry International ·Guylène Page, Sylvie Chalon, Patrick Emond, (unknown), Emmanuel Hermans	6
17	Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine 2002 ·Brain Research ·Magali Peeters, Guylène Page, Jean‐Marie Maloteaux, Emmanuel Hermans	41
18	Increased dopamine uptake in striatal synaptosomes after treatment of rats with amantadine 2000 ·European Journal of Pharmacology ·Guylène Page, Magali Peeters, Jean-Marie Maloteaux, Emmanuel Hermans	34
19	Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools 1998 ·Neurochemistry International ·Guylène Page, Sylvie Chalon, Laurence Barrier, Alain Piriou, François Huguet	6
20	Possible Relationship between Changes in [3H]DA Uptake and Autoxidation in Rat Striatal Slices 1998 ·Experimental Neurology ·Guylène Page, Laurence Barrier, (unknown), (unknown), Alain Piriou, François Huguet	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact